Several Asian countries have begun assessing the acceptability of the extrapolation of foreign clinical data for registration purposes. Some preliminary results of this evaluation process, which is intended to reduce duplication of clinical trials, have been reported. This article presents Taiwa's experience with this assessment and provides some suggestions for further improvements.
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.ICH Harmonised Tripartite Guideline: Ethnic Factors for the Acceptability of Foreign Clinical Data (E5).Geneva, Switzerland: International Conference on Harmonisation; 1996.
2.
NaitoC. Necessity and requirements of bridging studies and their present status in Japan. Int J Clin Pharamcol Ther.2000; 38:80–86.
3.
LinYLChiouYJHsiaoCLAssessment of extrapolation of foreign clinical data as a basis for registration purposes. Drug Inf J.2002; 36:513–516.
4.
HawkeyCJ. The gastroenterologist's caseload: Contribution of the rheumatologist. Semin Arthritis Rheum.1997; 26:11–15.
